Download PDFPDF

Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Use of Carbamazepine in the Treatment of Childhood Rolandic Epilepsy
    • Deb K. Pal, Professor
    • Other Contributors:
      • Louise C Mellish, Colin Dunkley and Colin D Ferrie

    Thanks to Moran and colleagues for pointing out another controversy surrounding the use of carbamazepine in idiopathic focal epilepsy. There has been concern, voiced mainly in paediatric neurology forums, of worsening of seizures (e.g. myoclonus) or of the development of electrical status epilepticus on the EEG in this situation. The risk is highlighted by the case reports cited in their letter, but this risk might not be...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Use of Carbamazepine in the Treatment of Childhood Rolandic Epilepsy

    Authors Maria Moran1, Nikolina Docheva2, William Whitehouse 1,2 1. Nottingham Children's Hospital, 2. University of Nottingham

    We were interested to read the article by Mellish et al.(1) which reports preference for carbamazepine first line for UK paediatricians treating Benign Rolandic Epilepsy (also known as Benign Epilepsy with Centrotemporal Spikes), perhaps better called Childhood Rolandic Epilepsy (CRE), a...

    Show More
    Conflict of Interest:
    None declared.